Country Trust Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82K Hold
38
﹤0.01% 542
2026
Q1
$1.4K Hold
38
﹤0.01% 499
2025
Q4
$1.93K Hold
38
﹤0.01% 515
2025
Q3
$2.11K Hold
38
﹤0.01% 512
2025
Q2
$2.62K Sell
38
-29
-43% -$1.97K ﹤0.01% 447
2025
Q1
$4.65K Buy
67
+29
+76% +$2.4K ﹤0.01% 275
2024
Q4
$3.27K Hold
38
﹤0.01% 295
2024
Q3
$4.53K Hold
38
﹤0.01% 288
2024
Q2
$5.42K Hold
38
﹤0.01% 272
2024
Q1
$4.88K Hold
38
﹤0.01% 261
2023
Q4
$3.93K Hold
38
﹤0.01% 271
2023
Q3
$3.46K Hold
38
﹤0.01% 267
2023
Q2
$3.08K Hold
38
﹤0.01% 270
2023
Q1
$3.02K Hold
38
﹤0.01% 264
2022
Q4
$2.57K Hold
38
﹤0.01% 288
2022
Q3
$2K Hold
38
﹤0.01% 349
2022
Q2
$2K Hold
38
﹤0.01% 350
2022
Q1
$2K Hold
38
﹤0.01% 392
2021
Q4
$2K Hold
38
﹤0.01% 457
2021
Q3
$2K Buy
+38
New +$1.84K ﹤0.01% 445

Other funds holding NVO

Country Trust Bank's NVO Position: Q2 2026 in Review

Country Trust Bank held its Novo Nordisk (NVO) position steady in Q2 2026 at 38 shares worth $1.82K. The position accounts for ﹤0.01% of the portfolio, ranked #542.

Country Trust Bank first reported a position in NVO in Q3 2021 and has held it in 20 quarters since. The position peaked at $5.42K in Q2 2024. 520 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Country Trust Bank held 38 shares of Novo Nordisk worth $1.82K as of Q2 2026.
  • Country Trust Bank left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Country Trust Bank's portfolio in Q2 2026, its #542 holding.
  • Country Trust Bank first reported a position in Novo Nordisk in Q3 2021 and has held it in 20 quarters since.
  • Country Trust Bank's Novo Nordisk position peaked at $5.42K in Q2 2024.
  • 520 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Country Trust Bank's 13F filing for Q2 2026, filed 15 Jul 2026.